Gain TherapeuticsGANX
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 33 institutions reported holding Gain Therapeutics Inc. (GANX) in their 13F filings, up 8 from Q4 2024. 10 opened new positions and 2 sold out. The largest holders were Gotham Asset Management ($3.2M), Greenlight Capital (DME Capital Management) ($1.1M) and Jones Financial Companies LLLP ($808K). 3 famous investors held it, including David Einhorn (0.1% of Greenlight Capital (DME Capital Management)'s portfolio), Joel Greenblatt (0.0% of Gotham Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Gain Therapeutics Inc.
- CUSIP
- 36269B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $454K |
| Exits | 2 | $42K |
All 13F filers, Q4 2024 → Q1 2025: 852,389 shares bought and 25,325 shares sold, net +827,064 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Gotham Asset Management | 0.03% | Reduce -2.6% | 153,984 | $3.2M |
| Greenlight Capital (DME Capital Management) | 0.05% | No change | 566,130 | $1.1M |
| Jones Financial Companies LLLP | 0.00% | Add +335.3% | 427,700 | $808K |
| Geode Capital Management, LLC | 0.00% | Add +5.5% | 282,211 | $539K |
| Vanguard Group Inc. | 0.00% | Add +44.0% | 254,990 | $487K |
| Marshall Wace, LLP | 0.00% | Add +113.7% | 196,026 | $374K |
| Dauntless Investment Group, LLC | 0.89% | New | 125,584 | $240K |
| Northern Trust Corp. | 0.00% | Add +18.4% | 100,170 | $191K |
| Morgan Stanley | 0.00% | Add +12.8% | 99,795 | $191K |
| Susquehanna International Group, LLP | 0.00% | Add +83.2% | 85,958 | $164K |
| BlackRock, Inc. | 0.00% | Reduce -1.9% | 84,407 | $161K |
| State Street Corp. | 0.00% | No change | 71,137 | $136K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +9.2% | 59,500 | $114K |
| NorthCoast Asset Management LLC | 0.00% | New | 47,578 | $91K |
| UBS Group AG | 0.00% | Add +23.1% | 43,360 | $83K |
| Prelude Capital Management, LLC | 0.01% | No change | 35,820 | $68K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 30,004 | $57K |
| Quadrature Capital Ltd | 0.00% | New | 20,154 | $38K |
| Citadel Advisors | 0.00% | Add +63.8% | 19,019 | $36K |
| Benedict Financial Advisors Inc. | 0.01% | Add +12.5% | 18,000 | $34K |
| Sandhill Capital Partners LLC | 0.00% | No change | 15,400 | $29K |
| Two Sigma Securities, LLC | 0.00% | New | 14,355 | $27K |
| Sprott Inc. | 0.00% | No change | 14,000 | $27K |
| Bison Wealth, LLC | 0.00% | New | 10,750 | $22K |
| NewEdge Advisors, LLC | 0.00% | New | 10,600 | $20K |
| Creekmur Asset Management LLC | 0.00% | No change | 4,440 | $8K |
| MAI Capital Management | 0.00% | No change | 4,410 | $8K |
| Bank of America Corp. | 0.00% | Add +0.4% | 4,102 | $8K |
| Simplex Trading, LLC | 0.00% | New | 3,444 | $6K |
| Wells Fargo & Company | 0.00% | No change | 2,650 | $5K |
| Arax Advisory Partners | 0.00% | New | 2,500 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,432 | $5K |
| FMR LLC | 0.00% | New | 80 | $154 |
"% of holder's portfolio" is GANX's weight in each manager's 13F, not the share of Gain Therapeutics Inc. the manager owns.